In ovarian cancer, MYC plays a critical role in tumor progression by promoting metabolic reprogramming, chemoresistance, and invasion, making it a key factor in disease recurrence and poor survival rates (Liu et al., 2024; Yi et al., 2019). This evidence concerns the gene MYC and ovarian carcinoma.